Back to Search
PANAGIOTIS FIDIAS, MD
MD
Medical Oncology Physician
NPI: 1396735585IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
77854(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
77854(MA)49332(AZ)
Education
OTHER
Class of 1990
Research & Publications (20)
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.
PMID 19139178·Ann Oncol·2009
3-trial
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
PMID 19075278·J Clin Oncol·2009
3-trial
A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.
PMID 18827612·J Thorac Oncol·2008
3-trial
Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancer.
PMID 18621626·Clin Lung Cancer·2008
3-trial
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
PMID 18543326·Cancer·2008
3-trial
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
PMID 18349397·J Clin Oncol·2008
3-trial
Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors.
PMID 18222230·Ann Thorac Surg·2008
8-other
A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies.
PMID 18199725·Cancer Epidemiol Biomarkers Prev·2008
3-trial
A phase II study of gefitinib in patients with advanced thyroid cancer.
PMID 17985985·Thyroid·2008
3-trial
Non-small cell lung cancer in octogenarians: treatment practices and preferences.
PMID 17975495·J Thorac Oncol·2007
8-other
Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
PMID 17557950·J Clin Oncol·2007
3-trial
Case records of the Massachusetts General Hospital. Case 16-2007. A 61-year-old man with a mediastinal mass.
PMID 17522403·N Engl J Med·2007
5-case
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.
PMID 17285735·Oncologist·2007
8-other
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.
PMID 17228019·J Clin Oncol·2007
3-trial
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
PMID 17036355·Cancer·2006
3-trial
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.
PMID 17075878·Cancer·2006
3-trial
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
PMID 17075122·J Clin Oncol·2006
3-trial
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2006. A 43-year-old woman with painful nodules on the fingertips, shortness of breath, and fatigue.
PMID 16990390·N Engl J Med·2006
5-case
Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
PMID 16857818·Clin Cancer Res·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5 ALUMNI DR
EXETER, NH 03833 - Phone
- (603) 580-7054
Quick Facts
- NPI
- 1396735585
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile